UA40895U - method for treatment of adhesions formation after laparoscopic organsaving operations on account of hysteromyoma or uterus endometriosis - Google Patents

method for treatment of adhesions formation after laparoscopic organsaving operations on account of hysteromyoma or uterus endometriosis

Info

Publication number
UA40895U
UA40895U UAU200814217U UAU200814217U UA40895U UA 40895 U UA40895 U UA 40895U UA U200814217 U UAU200814217 U UA U200814217U UA U200814217 U UAU200814217 U UA U200814217U UA 40895 U UA40895 U UA 40895U
Authority
UA
Ukraine
Prior art keywords
days
suppository
organsaving
hysteromyoma
laparoscopic
Prior art date
Application number
UAU200814217U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Игорь Зиновьевич Гладчук
Алла Георгиевна Волянская
Кирилл Витальевич Латий
Original Assignee
Одесский Государственный Медицинский Университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Одесский Государственный Медицинский Университет filed Critical Одесский Государственный Медицинский Университет
Priority to UAU200814217U priority Critical patent/UA40895U/en
Publication of UA40895U publication Critical patent/UA40895U/en

Links

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

A method for treatment of adhesions formation after laparoscopic organsaving operations on account of hysteromyoma or uterus endometriosis by using of basis antibacterial therapy including enzyme preparation prior to and after operation on the background of therapeutic physical training and intestine stimulation . As an enzyme the rectal disreptaze suppository is used two times per week daily prior to the operation 1 suppository during 5-6 days and after the operation during the first 3 days 1 suppository and next 6 days 1 suppository before going to bedin complex with therapeutic physical training, which consists in that after 12-16 hours the patient takes the position on its back with the angle of 30º-35º with obligatory lowering of head end of a bed during 15-20 minutes of total course of 6-7 days.
UAU200814217U 2008-12-10 2008-12-10 method for treatment of adhesions formation after laparoscopic organsaving operations on account of hysteromyoma or uterus endometriosis UA40895U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU200814217U UA40895U (en) 2008-12-10 2008-12-10 method for treatment of adhesions formation after laparoscopic organsaving operations on account of hysteromyoma or uterus endometriosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200814217U UA40895U (en) 2008-12-10 2008-12-10 method for treatment of adhesions formation after laparoscopic organsaving operations on account of hysteromyoma or uterus endometriosis

Publications (1)

Publication Number Publication Date
UA40895U true UA40895U (en) 2009-04-27

Family

ID=50620411

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200814217U UA40895U (en) 2008-12-10 2008-12-10 method for treatment of adhesions formation after laparoscopic organsaving operations on account of hysteromyoma or uterus endometriosis

Country Status (1)

Country Link
UA (1) UA40895U (en)

Similar Documents

Publication Publication Date Title
MX2019005130A (en) Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin.
MX2010004074A (en) Combination 059.
NZ612455A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
WO2010090878A3 (en) Apical papillary muscle attachment for left ventricular reduction
WO2011160062A3 (en) Compositions and methods for treating inflammatory conditions
WO2012006319A3 (en) Brain stimulation for enhancement of learning, motivation, and memory
MX2018009173A (en) USE OF sGC STIMULATORS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS (NASH).
WO2009074827A3 (en) Combination comprising a mek inhibitor and an aurora kinase inhibitor
MY170934A (en) Treatment of pain associated with dislocation of basal endometrium
MX348184B (en) Methods and compositions for treating hiv-associated diarrhea.
PH12017500392A1 (en) Medical treatments based on anamorelin
MX2018007152A (en) USE OF sGC STIMULATORS FOR THE TREATMENT OF GASTROINTESTINAL SPHINCTER DYSFUNCTION.
HK1124918A1 (en) Na, k-atpase expression in cervical dysplasia and cancer nak
WO2010137900A3 (en) Selective infracted-tissue-targeting bacteria and use thereof
UA40895U (en) method for treatment of adhesions formation after laparoscopic organsaving operations on account of hysteromyoma or uterus endometriosis
WO2010117992A3 (en) Coupled identification and treatment of cancer
MX2010007527A (en) Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases.
UA91136C2 (en) Peptide capable of stimulating the regeneration of neurons, pharmaceutical composition based thereon and method of use thereof
MY174186A (en) Use of an isopropanol-containing solution to combat caliciviridae
UA40165U (en) Method for evaluation of level of cortizol in patients with ischemic cardiac disease
UA39956U (en) Modified method for treatment of patients with the degenerative-dystrophic changes of spine lumbosacral area, caused by muscle spasm, with the use of phonophoresis
MX357949B (en) An apparatus for treating gerd.
UA60230U (en) Method for treating nonreversible forms of pulpitis
UA62661U (en) method for treatment and rehabilitation of patients with tubal-peritoneal infertility
UA59667U (en) method for medical rehabilitation of patients with nonalcoholic steatohepatitis using antihomotoxic treatment agents